Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana

Clinical trial NCT05986084 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05986084
Sponsor: Beth Israel Deaconess Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Pre-Exposure Prophylaxis (PrEP)Breast Feeding

Start date: 2023-11-30
Primary completion: 2027-08-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.